Pro Medicus Limited (ASX: PME)

Australia flag Australia · Delayed Price · Currency is AUD
116.01
-0.89 (-0.76%)
May 20, 2024, 4:10 PM AEST
95.17%
Market Cap 12.11B
Revenue (ttm) 142.12M
Net Income (ttm) 69.71M
Shares Out 104.43M
EPS (ttm) 0.67
PE Ratio 175.77
Forward PE 113.64
Dividend 0.35 (0.30%)
Ex-Dividend Date Feb 29, 2024
Volume 200,290
Open 117.50
Previous Close 116.90
Day's Range 116.01 - 119.09
52-Week Range 58.60 - 121.77
Beta 0.46
Analysts n/a
Price Target 101.55 (-12.46%)
Earnings Date Aug 13, 2024

About Pro Medicus

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and cli... [Read more]

Sector Healthcare
CEO Dr. Sam Aaron Hupert M.B.B.S., M.D.
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol PME
Full Company Profile

Financial Performance

In 2023, Pro Medicus's revenue was 124.90 million, an increase of 33.64% compared to the previous year's 93.46 million. Earnings were 60.65 million, an increase of 36.47%.

Financial Statements

News

Why Paradice is backing Seven Group’s bid for Boral

Mid cap investor Jovana Gagic says Kerry Stokes’ conglomerate has a good track record in buying controlling stakes, and reveals why she’s bullish on Orica and Pro Medicus.

5 weeks ago - The Australian Financial Review

ASX PME:

A $2.8 million share buyback helped restore $1.2 billion of value to Pro Medicus, and bulls think the stock – which is already trading at a sky-high multiple – has further to run.

3 months ago - The Australian Financial Review

Pro Medicus reports 1H results

3 months ago - Seeking Alpha

The Aussies hoping to make a fortune from Apple’s Vision Pro

The $11 billion ASX software giant Pro Medicus and a Melbourne start-up are among the businesses hoping to cash in on Apple’s new $5000 headset.

3 months ago - The Australian Financial Review

Pro Medicus founders in $176m selldown; Unified Capital nabs trade

Fund managers sources said Anthony Hall and Sam Hupert had stockbroker Unified Capital Partners seeking buyers for 2 million shares at $88 apiece.

6 months ago - The Australian Financial Review